Moderna’s Strategic Shift and Financial Outlook Leads to Sell Rating and Lowered Price Target
Leerink Partners analyst Mani Foroohar has reiterated their bearish stance on MRNA stock, giving a Sell rating on November 14.Don't Miss our ...
Vehicle crash causes delays near Tidewater Drive
A vehicle crash caused delays on I-64 near Tidewater Drive Tuesday morning. According to the Virginia Department of ...
S&P 500 Gains and Losses Today: Uber Falls as Trump Eyes Looser Self-Driving Rules
The S&P 500 added 0.4% on Monday, Nov. 18, kicking off a trading week that will feature a highly anticipated earnings report ...
Moderna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS Nomination
Moderna plans to prioritize new product approvals and oncology investments, as political concerns over Robert F. Kennedy Jr.'s HHS nomination weigh on vaccine stocks.
Moderna stock climbs as HSBC upgrades to Buy on underestimated pipeline potential
Shares in biotech firm Moderna (NASDAQ:MRNA) rose more than 4% Monday after HSBC raised its rating on the stock from Hold to Buy while trimming the target price to $58 from $82.
Cramer's Mad Dash: Moderna gets upgrade from HSBC
Mars didn’t always look like this. It may have once been covered in oceans. But what if we brought all the Martian water ...
Moderna upgraded to Hold from Reduce at HSBC
HSBC upgraded Moderna (MRNA) to Hold from Reduce with a $58 price target Don't Miss our Black Friday Offers:Discover the latest stocks ...
Moderna's stock decline after RFK Jr's appointment makes an "attractive entry point": Piper Sandler
Moderna’s ( NASDAQ: MRNA) steep fall on Friday after President-elect Donald Trump selected vaccine critic Robert F. Kennedy Jr. to head the U.S. Department of Health and Human Services makes a good ...
The Art Newspaper23h
Lisbon’s museum scene booms as new and revamped institutions are unveiled
With the reopening of the Centro de Arte Moderna Gulbenkian, the Portuguese capital is developing a lively contemporary art ...